Emmessar Biotech & Nutrition share news, announcements and annual reports
BSE: 524768Chemicals & PetrochemicalsSmall Cap
Emmessar Biotech & Nutrition Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1995
Last close ₹23.63up ₹0.77 (3.37%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹22.86.
30 Oct: open ₹23.59, high ₹23.66, low ₹23.59
52-week range of traded prices to 30 Oct 2026
₹18.42Low, 24 Mar 2026₹33.38High, 20 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹12 Cr4,463rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 27.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3
Emmessar Biotech & Nutrition results
87 filed, newest first. Page 2 of 2.
Aug 2017
Jun 2017
May 2017
Jan 2017
Oct 2016
Aug 2016
May 2016
Feb 2016
Dec 2015
Nov 2015
Sep 2015
Aug 2015
May 2015
Feb 2015
Jan 2015
Oct 2014
Aug 2014
Jul 2014
May 2014
22 May · Results
Feb 2014
Nov 2013
Aug 2013
May 2013
30 May · Results
Jan 2013
Nov 2012
Jul 2012
12 Jul · Results
May 2012
10 May · Results
Feb 2012
Oct 2011
24 Oct · Results
Jul 2011
29 Jul · Results
Apr 2011
26 Apr · Results
Jan 2011
28 Jan · Results
Oct 2010
27 Oct · Results
Jul 2010
30 Jul · Results
May 2010
Feb 2010
3 Feb · Results